Try our Advanced Search for more refined results

February 23, 2023

Securities and Exchange Commission v. Markman Biologics Corp. et al

Track this case

Case Number:

2:23-cv-00288

Court:

Nevada

Nature of Suit:

Securities/Commodities

Judge:

Andrew P. Gordon

Firms

Government Agencies

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. February 24, 2023

    Skin Graft Co. CEO Ran $1.3M Investor Grift, SEC Claims

    The U.S. Securities and Exchange Commission has filed suit against a Nevada medical technology company and its CEO, claiming they scammed at least 85 investors out of nearly $1.3 million via four fraudulent, unregistered offerings.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login